167 related articles for article (PubMed ID: 17347381)
1. Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans.
Walsh S; Metter EJ; Ferrucci L; Roth SM
J Appl Physiol (1985); 2007 Jun; 102(6):2142-8. PubMed ID: 17347381
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variant in ACVR2B Is Associated with Lean Mass.
Klimentidis YC; Bea JW; Thompson P; Klimecki WT; Hu C; Wu G; Nicholas JS; Ryckman KK; Chen Z
Med Sci Sports Exerc; 2016 Jul; 48(7):1270-5. PubMed ID: 26848890
[TBL] [Abstract][Full Text] [Related]
3. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.
Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T
BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and maximal eccentric exercise alters myostatin-related gene expression in postmenopausal women.
Dieli-Conwright CM; Spektor TM; Rice JC; Sattler FR; Schroeder ET
J Strength Cond Res; 2012 May; 26(5):1374-82. PubMed ID: 22395277
[TBL] [Abstract][Full Text] [Related]
5. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span.
Walsh S; Liu D; Metter EJ; Ferrucci L; Roth SM
J Appl Physiol (1985); 2008 Nov; 105(5):1486-91. PubMed ID: 18756004
[TBL] [Abstract][Full Text] [Related]
6. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway.
Lee SJ; Huynh TV; Lee YS; Sebald SM; Wilcox-Adelman SA; Iwamori N; Lepper C; Matzuk MM; Fan CM
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):E2353-60. PubMed ID: 22869749
[TBL] [Abstract][Full Text] [Related]
7. Strength training with blood flow restriction diminishes myostatin gene expression.
Laurentino GC; Ugrinowitsch C; Roschel H; Aoki MS; Soares AG; Neves M; Aihara AY; Fernandes Ada R; Tricoli V
Med Sci Sports Exerc; 2012 Mar; 44(3):406-12. PubMed ID: 21900845
[TBL] [Abstract][Full Text] [Related]
8. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
[TBL] [Abstract][Full Text] [Related]
9. Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis.
Carrarelli P; Yen CF; Arcuri F; Funghi L; Tosti C; Wang TH; Huang JS; Petraglia F
Fertil Steril; 2015 Sep; 104(3):744-52.e1. PubMed ID: 26086422
[TBL] [Abstract][Full Text] [Related]
10. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
[TBL] [Abstract][Full Text] [Related]
11. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
Lee SJ; Reed LA; Davies MV; Girgenrath S; Goad ME; Tomkinson KN; Wright JF; Barker C; Ehrmantraut G; Holmstrom J; Trowell B; Gertz B; Jiang MS; Sebald SM; Matzuk M; Li E; Liang LF; Quattlebaum E; Stotish RL; Wolfman NM
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18117-22. PubMed ID: 16330774
[TBL] [Abstract][Full Text] [Related]
12. Effects of heavy resistance training on myostatin mRNA and protein expression.
Willoughby DS
Med Sci Sports Exerc; 2004 Apr; 36(4):574-82. PubMed ID: 15064583
[TBL] [Abstract][Full Text] [Related]
13. Regulation of muscle mass by follistatin and activins.
Lee SJ; Lee YS; Zimmers TA; Soleimani A; Matzuk MM; Tsuchida K; Cohn RD; Barton ER
Mol Endocrinol; 2010 Oct; 24(10):1998-2008. PubMed ID: 20810712
[TBL] [Abstract][Full Text] [Related]
14. Post-mortem stability of RNA in skeletal muscle and adipose tissue and the tissue-specific expression of myostatin, perilipin and associated factors in the horse.
Morrison PK; Bing C; Harris PA; Maltin CA; Grove-White D; Argo CM
PLoS One; 2014; 9(6):e100810. PubMed ID: 24956155
[TBL] [Abstract][Full Text] [Related]
15. TNF promoter polymorphisms associated with muscle phenotypes in humans.
Liu D; Metter EJ; Ferrucci L; Roth SM
J Appl Physiol (1985); 2008 Sep; 105(3):859-67. PubMed ID: 18635873
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
17. The influence of eccentric exercise on mRNA expression of skeletal muscle regulators.
Jensky NE; Sims JK; Rice JC; Dreyer HC; Schroeder ET
Eur J Appl Physiol; 2007 Nov; 101(4):473-80. PubMed ID: 17661068
[TBL] [Abstract][Full Text] [Related]
18. Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity.
Kostek MA; Angelopoulos TJ; Clarkson PM; Gordon PM; Moyna NM; Visich PS; Zoeller RF; Price TB; Seip RL; Thompson PD; Devaney JM; Gordish-Dressman H; Hoffman EP; Pescatello LS
Med Sci Sports Exerc; 2009 May; 41(5):1063-71. PubMed ID: 19346981
[TBL] [Abstract][Full Text] [Related]
19. Follistatin N terminus differentially regulates muscle size and fat in vivo.
Zheng H; Qiao C; Tang R; Li J; Bulaklak K; Huang Z; Zhao C; Dai Y; Li J; Xiao X
Exp Mol Med; 2017 Sep; 49(9):e377. PubMed ID: 28912572
[TBL] [Abstract][Full Text] [Related]
20. The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs.
Chang F; Fang R; Wang M; Zhao X; Chang W; Zhang Z; Li N; Meng Q
Transgenic Res; 2017 Feb; 26(1):25-36. PubMed ID: 27787698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
